![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Report Says DoD Reliance on Foreign Drugmakers Poses Security Risk
Report Says DoD Reliance on Foreign Drugmakers Poses Security Risk
September 28, 2021
The Department of Defense (DoD) is overly reliant on foreign drug supply chains, a problem that could spell big trouble not only for the military, but the entire country, says a new report from the DOD’s Office of the Inspector General (OIG).
“The DoD’s reliance on foreign suppliers for pharmaceuticals is a public health, readiness and national security risk,” the OIG said. “Senior officials … stated that if some countries decide to stop producing [active pharmaceutical ingredients] or shipping them to the domestic manufacturers in the United States, the results could be catastrophic for the entire U.S. pharmaceutical industry.”
The risks have been well-known for years, but the Department of Defense has neither assessed them nor solved any of the problems they present, as required by a 2019 DoD Supply Chain Material Management Policy, the document notes.
Upcoming Events
-
21Oct